While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

Billion in New Commitments Closed in the Fourth Quarter, Reaching a Record of $48.2 Billion Closed in the 12 Months Ended December 31, 2024 NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Ares ...

Drugmaker pauses HPV Gardasil exports as rival Pfizer gets boost from better than expected Covid vaccine and pill sales ...

Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

MSD Global Health Innovation Fund, a corporate venture capital arm of Merck & Co., Inc., Rahway, NJ, USA, who became an Evaxion shareholder in December 2023, participated in this offering along with ...

Evaxion Biotech (EVAX) announced the pricing of a public offering of an aggregate of 3,997,361 of its American Depositary Shares and warrants ...

Evaxion Biotech (EVAX) shares dropped 25% premarket after pricing a $10.8M public offering to advance its preclinical and clinical pipeline.

The US Food and Drug Administration (FDA) will soon decide on whether to expand the label of MSD’s Welireg (belzutifan) to ...

Look at recent big pharma asset acquisitions and new biotech company launches, and you might spot a common theme: The drugs at the heart of these deals were originally developed in China.

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

(Bloomberg) -- Goldman Sachs Group Inc. veteran Greg Olafson is leaving the firm to join merchant bank BDT & MSD Partners as president, co-head of global credit and co-chief investment officer.